Associate Professor of Pediatrics, University Colorado
Pediatric Hematology & Oncology
Dr. Lia Gore, MD
|
|
Give Review
Doctor Lia Gore, MD works in the field of Pediatric Hematology & Oncology. She went to medical school at George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care She received 1 awards: "Regional Top Doctor". Gore is a published physician. She published 15 publications, including: 'Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report fro...'
Publications
- Decreased induction morbidity and mortality following modification to induction therapy in infants with Acute lymphoblastic leukemia enrolled on AALL0631: A report fro...
- Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
- Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.
- Inhibition of calcineurin combined with dasatinib has direct and indirect anti-Leukemia effects against BCR-ABL1(+) Leukemia.
- A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors.
- A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
- Overview of Therapy and Strategies for Optimizing Outcomes in De Novo Pediatric Acute Myeloid Leukemia.
- Phase 1 study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid Malignancies.
- A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors.
- Pulmonary Presentation of Relapsed Acute Myeloid Leukemia.
- A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.
- Targeting developmental pathways in children with Cancer: what price success?
- A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
- Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications.
Schools
George Washington University School Of Medicine and Health Sciences
George Washington UniversityChildren39s National Medical Center Program
University Of Colorado Children S Hospital Colorado Program
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Hodgkin's Disease
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Colorado -
George Washington University -
George Washington University School of Medicine
Hospital
-
University of Colorado Hospital -
Children's Hospital Colorado
Helpful Reviews
Similar Doctors
|
Dr. Nicole A. McKinney, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Taru Hays, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taizo A. Nakano, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel R. Ambruso, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christopher C. Silliman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Abdulrahman S. Alsultan, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl T. Kisker, MD
This Doctor is OpenDoctor Recommended.
|